Carbapenemase-producing Gram-negative Microorganisms: Detection, Epidemiology and Therapeutic Challanges, ESCMID Postgraduate Education Course
1 - 2 December 2011, Athens, Greece
Course Materials
Presentations are available for ESCMID members exclusively. Please log in or register.
Thursday, 1 December 2011
I. Classification and Epidemiology of Carbapenemases | |
|---|---|
08:45–09:15 | Introduction to beta-lactamases. Irene Galani (GR) |
09:15–10:00 | Classification and hydrolytic activity of carbapenemases. Vivi Miriagou (GR) |
10:00–10:45 | Genetic structures at the origin of acquisition of the carbapenemase genes. Laurent Poirel (FR) |
II. Laboratory Issues | |||
|---|---|---|---|
11:30–12:00 | When to suspect the presence of carbapenemases. Methods for phenotypic detection. Athanassios Tsakris (GR) | ||
12:00–12:30 | The rationale behind the EUCAST susceptibility breakpoints and new expert rules for carbapenems. Rafael Canton (ES) | ||
12:30–13:00 | How to effectively report laboratory findings to clinicians (Breakpoints and Interpretation). Alkis Vatopoulos (GR) | ||
III. Carbapenemase-Producing Bacteria: International Experience | |
|---|---|
14:00–14:30 | The European experience on carbapenemases. Gian Maria Rossolini (IT) |
14:30–15:00 | The Israeli and USA experience on carbapenemases. Yehuda Carmeli (IL) |
15:00–15:30 | The Greek experience on carbapenemases. Maria Souli (GR) |
Friday, 2 December 2011
IV. Therapeutic Challenges | |
|---|---|
09:00–09:30 | Carbapenemase-producing Enterobacteriaceae with low-level resistance to carbapenems: Do we have more treatment options? George L. Daikos (GR) |
09:30–10:00 | Colistin in the treatment of infections by carbapenemase-producing bacteria. Diamantis Plachouras (GR) |
10:00–10:30 | Tigecycline in the treatment of infections by carbapenemase-producing bacteria. Garyphallia Poulakou (GR) |
10:30–11:00 | Fosfomycin in the treatment of infections by carbapenemase-producing bacteria. Helen Giamarellou (GR) |
V. Laboratory Rounds and Case Presentations | |
|---|---|
12:45–13:45 | Case Presentations: From the agar plate to the patient |
VI. Prevention and Control | |
|---|---|
14:30–15:00 | Infection control issues. Anastasia Antoniadou (GR) |
15:00–15:30 | Focusing on antibiotic stewardship. Helen Giamarellou (GR) |
Course Faculty
- Anastasia Antoniadou, Athens, GR
- Rafael Canton, Madrid, ES
- Yehuda Carmeli, Tel Aviv, IL
- George L. Daikos, Athens, GR
- Irene Galani, Athens, GR
- Helen Giamarellou, Athens, GR
- Vivi Miriagou, Athens, GR
- Diamantis Plachouras, Athens, GR
- Laurent Poirel, Paris, FR
- Garyphallia Poulakou, Athens, GR
- Gian Maria Rossolini, Siena, IT
- Maria Souli, Athens, GR
- Athanassios Tsakris, Athens, GR
- Alkis Vatopoulos, Athens, GR
Contact Person
Helen Giamarellou
Phone +30 2106867946
Fax +30 2106867377
Administartive Secretariat
Imagine Congress and Travel
Mrs Vanna Antonopoulou & Mrs Christina Luthi
Kolokotroni str 9
10562 Athens, Greece
Tel +30 210 3252520
Fax +30210 3252530
Course Objectives
The course participants will be able to:
- Review the current knowledge on epidemiology of carbapenemase-producers.
- Recognise or suspect Carbapenemase-producing microorganisms at the laboratory level and proceed to further identification.
- Understand and support the infection control issues which will prevent the spread of carbapenemase-producing microorganisms in their institutions.
- Discuss treatment options against carbapenemase-producing pathogens as well as the appropriate antibiotic stewardship.
Target Audience
60 - 100 infectious disease physicians and clinical microbiologists
